Anusol Suppositories 10 mg
Natural health product licensed in Canada
- Licence holder
- Church & Dwight Canada Corp.
- NPN or DIN-HM
- 01945920
- Status
- Active licence
- Licence date
- 10 March 2008
- Revision date
- 8 December 2021
- Form
- Suppositoire
- Route of administration
- Rectale
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Phosphate de calcium, dibasique, Huile végétale hydrogénée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 suppositoire | 1 Tous les jours |
| Enfants | Not specified | 1 suppositoire | 1 Tous les jours |
Uses authorised in Canada
Relief from the discomfort of hemorrhoids.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
N/A
- Contre-indications
N/A
- Effets indésirables connus
N/A
Source
Official Health Canada record, licence 01945920
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging